Method of screening multiple sclerosis biomarkers
A biomarker, multiple sclerosis technology, applied in the field of bioinformatics, can solve the problem of not considering the interconnection of genes and difficult to reflect the real situation of patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0023] A method for screening multiple sclerosis disease biomarkers, comprising the steps of:
[0024] (1) Obtain the dataset GSE21942 from the GEO database (http: / / www.ncbi.nlm.nih.gov / geo / ), the platform is GPL570, and the sample contains peripheral blood samples from 15 normal people and 14 MS patients For nuclear cell gene expression profiles, the samples were standardized using MAS5;
[0025] (2) x and y represent two genes respectively, using the formula (|(x(i)+y(i)) / (x(j)+y(j))-1|<δ(i,j=1 ,2,...,N), remove the x or y genes with unchanged expression, screen out the mutually inhibited gene pairs (x, y), and obtain multiple sclerosis disease biomarkers; where: δ represents gene x The degree of approximation to y is taken as δ=0.08 in the experiment; x(i) represents the gene expression of the i-th sample of gene x, and y(i) represents the gene expression of the i-th sample of gene y (assuming a total of N samples); the screening is implemented by writing codes in MATLAB....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com